Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pepper Schedin

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Breast Cancer Research : BCR|March 23, 2016
COX-2 modulates mammary tumor progression in response to collagen densityKarla Esbona, David Inman, Sandeep Saha, et al.
Nutrition and Cancer|September 19, 2002
Adolescent vitamin A intake alters susceptibility to mammary carcinogenesis in the Sprague-Dawley ratRichard P Metz, Mark Kaeck, Maria Stacewicz-Sapuntzakis, et al.
Experimental Cell Research|May 14, 2013
Developmental windows of breast cancer risk provide opportunities for targeted chemopreventionHolly A Martinson, Traci R Lyons, Erin D Giles, et al.
Molecular & Cellular Proteomics : MCP|April 9, 2009
An in-solution ultrasonication-assisted digestion method for improved extracellular matrix proteome coverageKirk C Hansen, Lauren Kiemele, Ori Maller, et al.
Carcinogenesis|July 15, 2006
Inhibition of breast cancer growth and invasion by single-minded 2sHyeong-Il Kwak, Tanya Gustafson, Richard P Metz, et al.
Experimental Cell Research|January 9, 2026
S-Nitrosylated COX-2 is a microenvironment-regulated breast cancer cell biomarker of mesenchymal phenotypesReuben J Hoffmann, AeSoon Bensen, Mark Dane, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
S-Nitrosylated COX-2 is a TME-regulated breast cancer biomarker of mesenchymal phenotypesReuben J Hoffmann, AeSoon Bensen, Mark Dane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2018
Mucosal Immunity in the Female Murine Mammary GlandCourtney B Betts, Nathan D Pennock, Breanna P Caruso, et al.
Endocrinology|May 16, 2019
NHERF1 Is Required for Localization of PMCA2 and Suppression of Early Involution in the Female Lactating Mammary GlandJaekwang Jeong, Wonnam Kim, Julie Hens, et al.
The American Journal of Pathology|September 8, 2015
Myoepithelial cell differentiation markers in ductal carcinoma in situ progressionTanya D Russell, Sonali Jindal, Samiat Agunbiade, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Breast Cancer Research : BCR|March 23, 2016
COX-2 modulates mammary tumor progression in response to collagen densityKarla Esbona, David Inman, Sandeep Saha, et al.
Nutrition and Cancer|September 19, 2002
Adolescent vitamin A intake alters susceptibility to mammary carcinogenesis in the Sprague-Dawley ratRichard P Metz, Mark Kaeck, Maria Stacewicz-Sapuntzakis, et al.
Experimental Cell Research|May 14, 2013
Developmental windows of breast cancer risk provide opportunities for targeted chemopreventionHolly A Martinson, Traci R Lyons, Erin D Giles, et al.
Molecular & Cellular Proteomics : MCP|April 9, 2009
An in-solution ultrasonication-assisted digestion method for improved extracellular matrix proteome coverageKirk C Hansen, Lauren Kiemele, Ori Maller, et al.
Carcinogenesis|July 15, 2006
Inhibition of breast cancer growth and invasion by single-minded 2sHyeong-Il Kwak, Tanya Gustafson, Richard P Metz, et al.
Experimental Cell Research|January 9, 2026
S-Nitrosylated COX-2 is a microenvironment-regulated breast cancer cell biomarker of mesenchymal phenotypesReuben J Hoffmann, AeSoon Bensen, Mark Dane, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
S-Nitrosylated COX-2 is a TME-regulated breast cancer biomarker of mesenchymal phenotypesReuben J Hoffmann, AeSoon Bensen, Mark Dane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2018
Mucosal Immunity in the Female Murine Mammary GlandCourtney B Betts, Nathan D Pennock, Breanna P Caruso, et al.
Endocrinology|May 16, 2019
NHERF1 Is Required for Localization of PMCA2 and Suppression of Early Involution in the Female Lactating Mammary GlandJaekwang Jeong, Wonnam Kim, Julie Hens, et al.
The American Journal of Pathology|September 8, 2015
Myoepithelial cell differentiation markers in ductal carcinoma in situ progressionTanya D Russell, Sonali Jindal, Samiat Agunbiade, et al.
Pageof 10